Literature DB >> 14976284

Emerging infectious diseases. Nipah virus (or a cousin) strikes again.

Martin Enserink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14976284     DOI： 10.1126/science.303.5661.1121b

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  21 in total

1.  Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Authors:  Zhongyu Zhu; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Kimberly A Bishop; Vidita Choudhry; Bruce A Mungall; Yan-Ru Feng; Anil Choudhary; Mei-Yun Zhang; Yang Feng; Lin-Fa Wang; Xiaodong Xiao; Bryan T Eaton; Christopher C Broder; Dimiter S Dimitrov
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.

Authors:  Alexander Freiberg; Lhia Krista Dolores; Sven Enterlein; Ramon Flick
Journal:  Virology       Date:  2007-09-27       Impact factor: 3.616

3.  Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screening.

Authors:  Mohamad Aljofan; Simon Saubern; Adam G Meyer; Glenn Marsh; Joanne Meers; Bruce A Mungall
Journal:  Virus Res       Date:  2009-01-29       Impact factor: 3.303

4.  Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.

Authors:  Matthew I Bonaparte; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Bruce A Mungall; Kimberly A Bishop; Vidita Choudhry; Dimiter S Dimitrov; Lin-Fa Wang; Bryan T Eaton; Christopher C Broder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-05       Impact factor: 11.205

5.  Establishment of a Nipah virus rescue system.

Authors:  Misako Yoneda; Vanessa Guillaume; Fusako Ikeda; Yuki Sakuma; Hiroki Sato; T Fabian Wild; Chieko Kai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

6.  Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach.

Authors:  Anasuya Chattopadhyay; John K Rose
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

7.  A single amino acid substitution in the V protein of Nipah virus alters its ability to block interferon signalling in cells from different species.

Authors:  Kathrin Hagmaier; Nicola Stock; Steve Goodbourn; Lin-Fa Wang; Richard Randall
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

8.  Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.

Authors:  Matteo Porotto; Barry Rockx; Christine C Yokoyama; Aparna Talekar; Ilaria Devito; Laura M Palermo; Jie Liu; Riccardo Cortese; Min Lu; Heinz Feldmann; Antonello Pessi; Anne Moscona
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

9.  The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals.

Authors:  Misako Yoneda; Vanessa Guillaume; Hiroki Sato; Kentaro Fujita; Marie-Claude Georges-Courbot; Fusako Ikeda; Mio Omi; Yuri Muto-Terao; T Fabian Wild; Chieko Kai
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

10.  Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro.

Authors:  Mohamad Aljofan; Michael L Sganga; Michael K Lo; Christina L Rootes; Matteo Porotto; Adam G Meyer; Simon Saubern; Anne Moscona; Bruce A Mungall
Journal:  Virol J       Date:  2009-11-04       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.